IS:AUROPHARMA Aurobindo Pharma Limited

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of various pharmaceutical products in India. It produces oral and injectable generic formulations, and active pharmaceutical ingredients in the areas of antibiotic, anti-retroviral, cardiovascular, central nervous system, gastroenterological, anti-allergy, and anti-diabetic areas. The company also provides custom research and manufacturing services to bio-tech and pharmaceutical community; develop and manufactures peptides; and invents, identifies, and produces biocatalysts and fermentation processes for use in the pharmaceutical and chemical industries. In addition, it manufactures and sells vitamins, minerals, and supplements; diet and weight management products; sports nutrition products; and products for hair, skin, and nails. The company also exports its products to approximately 150 countries, including the United States and Europe. It serves multinational companies. Aurobindo Pharma Limited was founded in 1986 and is headquartered in Hyderabad, India.

616.85 INR
As of 01/25/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  12/31/1999
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   388,557,504,512 INR
Current dividend yield:   0.88%
Sedol:      6702634

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy